Journals / Diagnostic and Interventional Radiology / 2022 / Cilt: 28 - Sayı: 3

Distinguishing T1-2 and T3a tumors of rectal cancer with texture analysis and functional MRI parameters

Pages
200–207
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The application of above combinations could be beneficial to patients’ accurate and individualized treatments.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:PURPOSE We aimed to investigate whether the texture analysis and functional magnetic resonance imaging (fMRI) could differentiate rectal cancer pathological stages T1-2 (pT1-2) and T3a (pT3a).
📊
Key Findings & Data:METHODS Eighty-two rectal adenocarcinoma patients at stage pT1-2 and pT3a received T2 and fMRI examination before surgery.
💡
Conclusion & Impact:The application of above combinations could be beneficial to patients’ accurate and individualized treatments.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

PURPOSE We aimed to investigate whether the texture analysis and functional magnetic resonance imaging (fMRI) could differentiate rectal cancer pathological stages T1-2 (pT1-2) and T3a (pT3a). METHODS Eighty-two rectal adenocarcinoma patients at stage pT1-2 and pT3a received T2 and fMRI examination before surgery. The latter included apparent diffusion coefficient (ADC) sequence, dynamic contrast enhancement (DCE) MRI, and intravoxel incoherent motion (IVIM) diffusion weighted imaging. Patients were grouped into early stage (pT1-2) and advanced stage (pT3a). The MRI accuracy in diagnosing rectal cancer before surgery was calculated. The differences in clinicopathological variables, quantitative parameters including ADC values, IVIM parameters (perfusion fraction [f], true diffusion coefficient [D], and pseudodiffusion coefficient [D*]), DCE MRI parameters (transfer constant [Ktrans], reflux constant [Kep], and extravascular extracellular fractional volume [Ve]), and texture features were compared between the groups. Receiver operating characteristic (ROC) curves of texture features and fMRI parameters were generated to distinguish pT1-2 and pT3a tumors. The multivariate analysis was used to develop a predictive model and to find independent risk factors. Hosmer–Lemeshow test was used to see the fitness of the model. DeLong test was applied to compare the ROC curves of different features. Correlation of texture features and fMRI parameters with stage were calculated using r (Spearman’s rank correlation coefficient). RESULTS The preoperative accuracy in differentiating pT1-2 from pT3a rectal cancer using MRI was 74.39%. Kep, Ve, and ADC showed significant differences between the groups. Kep and ADC showed negative correlation with stage. Ve correlated positively with stage. Twenty-five texture features from T2 images showed significant differences between groups, and S(0,2)SumOfSqs and WavEnLH_s_2 among these showed better performance, showing negative correlation with stage. The area under the curve (AUC) values of S(0,2)SumOfSqs, WavEnLH_s_2, ADC, Kep, and Ve were 0.721, 0.699, 0.690, 0.666, and 0.653, respectively. Themultivariate analysis showed that S(0,2) SumOfSqs, WavEnLH_s_2, and ADC are risk factors for advanced tumors, and the logistic model built by Kep, Ve, S(0,2)SumOfSqs, WavEnLH_s_2, and ADC has the AUC, sensitivity, and specificity of 0.833, 88.5%, and 73.3%, respectively. ROC curve of the model showed statistical significance between S(0,2)SumOfSqs, ADC, Kep, and Ve. The P value of the Hosmer–Lemeshow test was 0.65. CONCLUSION S(0,2)SumOfSqs, WavEnLH_s_2, and ADC are risk factors for advanced rectal cancer, and the model built by Kep, Ve, S(0,2)SumOfSqs, WavEnLH_s_2, and ADC has better performance than using a single method. The application of above combinations could be beneficial to patients’ accurate and individualized treatments.

🔖

Cite This Article

SUN, D., WU, X., WANG, L., LI, G., HUANG, J., LI, Y. (2022). Distinguishing T1-2 and T3a tumors of rectal cancer with texture analysis and functional MRI parameters. Diagnostic and Interventional Radiology, Cilt: 28 - Sayı: 3, 200–207. https://ajindex.com/articles/487249

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Balyasnikova S, Brown G. Optimal imaging strategies for rectal cancer staging and ongoing management. Curr Treat Options Oncol. 2016
  2. 17(6):32. [Crossref] 2. DeSantis CE, Lin CC, Mariotto AB, et al. Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin. 2014
  3. 64(4):252-271. [Crossref] 3. Ludmir EB, Palta M, Willett CG, Czito BG. Total neoadjuvant therapy for rectal cancer: An emerging option. Cancer. 2017
  4. 123(9):1497- 1506. [Crossref] 4. Palmucci S, Piccoli M, Piana S, et al. DiffusionMRI for rectal cancer staging: ADC measurements before and after ultrasonographic gel lumen distension. Eur J Radiol. 2017
  5. [Crossref] 5. Horvat N, Carlos Tavares Rocha C, Clemente OB, Petkovska I, Gollub MJ. MRI of rectal cancer: Tumor staging, imaging techniques, and management. Radiographics. 2019
  6. 39(2):367- 387. [Crossref] 6. Danihel LJr., Danihel LSr., Rajcok M, et al. Significance of MRI in rectal carcinoma therapy optimization - correlation of preoperative T- and N-staging with definitive histopathological findings. Neoplasma. 2019
  7. 66(3):494-498. [Crossref] 7. Taylor FG, Swift RI, Blomqvist L, Brown G. A systematic approach to the interpretation of preoperative staging MRI for rectal cancer. AJR Am J Roentgenol. 2008
  8. 191(6):1827-1835. [Crossref] 8. Laghi A, FerriM, Catalano C, et al. Local staging of rectal cancerwithMRI using a phased array body coil. Abdom Imaging. 2002
  9. 27(4):425-431. [Crossref] 9. Hoeffel C, Mule S, Laurent V, Bouche O, Volet J, Soyer P. Primary rectal cancer local staging. Diagn Interv Imaging. 2014
  10. 95(5):485-494. [Crossref] 10. Boot J, Gomez-Munoz F, Beets-Tan RGH. Imaging of rectal cancer. Radiologe. 2019
  11. 59(Suppl 1):46-50. [Crossref] 11. Sun Y, Tong T, Cai S, Bi R, Xin C, Gu Y. Apparent Diffusion Coefficient (ADC) value: A potential imaging biomarker that reflects the biological features of rectal cancer. PLoS One. 2014
  12. 9(10): e109371. [Crossref] 12. Surov A, Meyer HJ, Hohn AK, et al. Correlations between intravoxel incoherent motion (IVIM) parameters and histological findings in rectal cancer: Preliminary results. Oncotarget. 2017
  13. 8 (13):21974-21983. [Crossref] 13. Gurses B, Boge M, Altinmakas E, Balik E. Multiparametric MRI in rectal cancer. Diagn Interv Radiol. 2019
  14. 25(3):175-182. [Crossref] 14. Ganeshan B, Goh V, Mandeville HC, Ng QS, Hoskin PJ, Miles KA. Non-small cell lung cancer: Histopathologic correlates for texture parameters at CT. Radiology. 2013
  15. 266(1):326-336. [Crossref] 15. Liang C, Huang Y, He L, et al.